Please provide your email address to receive an email when new articles are posted on . In early August, the FDA approved neffy epinephrine nasal spray to treat emergent type 1 allergic ...
A nasal spray to treat life-threatening allergic reactions has been given the green light by US regulators. Anaphylaxis, a severe and potentially fatal allergic reaction, requires immediate ...
The changing of seasons is often accompanied by undesirable side effects known as seasonal allergies. Seasonal allergies plague many people due to the sudden presence of specific plant pollen that ...
An everyday hay fever spray may do more than tame sneezes. In a rigorously run German trial, adults who used azelastine nasal spray three times a day were less likely to catch COVID-19 than ...
Please provide your email address to receive an email when new articles are posted on . ARS Pharma recently announced that the FDA will likely rule on a new drug application for the company’s neffy ...
Many consumers are familiar with EpiPens and other epinephrine injectables when treating severe allergic reactions. Now, the Food and Drug Administration (FDA) has approved the first non-injectable ...
The incidence of provider-diagnosed AR in the United States is approximately 60 million people, including both adults and children. 2 The incidence is even higher when patients self-report AR: between ...
The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ARS Pharmaceuticals, ...
Spring can be a difficult season for allergy sufferers, but relief is always close at hand with this in your toolkit.
GoodRx reports that seniors should use corticosteroid nasal sprays and avoid drowsy antihistamines like Benadryl to minimize ...
There's a warning that using a nasal decongestant spray for more than five days could make a blocked nose worse.